FN075

CAS No. 864405-82-3

FN075( FN 075 )

Catalog No. M16269 CAS No. 864405-82-3

FN075 is a small-molecule inhibitor targeting Escherichia coli amyloid biogenesis and biofilm formation.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    FN075
  • Note
    Research use only, not for human use.
  • Brief Description
    FN075 is a small-molecule inhibitor targeting Escherichia coli amyloid biogenesis and biofilm formation.
  • Description
    FN075 is a small-molecule inhibitor targeting Escherichia coli amyloid biogenesis and biofilm formation; stimulates α-synuclein amyloid fiber formation; significantly attenuates virulence in a mouse model of urinary tract infection.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    FN 075
  • Pathway
    GPCR/G Protein
  • Target
    Antibacterial
  • Recptor
    Antibacterial
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    864405-82-3
  • Formula Weight
    481.489
  • Molecular Formula
    C26H18F3NO3S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    (R)-7-(naphthalen-1-ylmethyl)-5-oxo-8-(3-(trifluoromethyl)phenyl)-2,3-dihydro-5H-thiazolo[3,2-a]pyridine-3-carboxylic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Cegelski L, et al. Nat Chem Biol. 2009 Dec;5(12):913-9. 2. Clark MA, et al. Nat Chem Biol. 2009 Sep;5(9):647-54. 3. Nors Perdersen M, et al. Sci Rep. 2015 May 28;5:10422.
molnova catalog
related products
  • Paromomycin Sulfate

    Paromomycin Sulfate is an aminoglycoside antibiotics inhibiting protein synthesis in non-resistant cells by binding to 16S ribosomal RNA.

  • Midecamycin

    Midecamycin an acetoxy-substituted macrolide antibiotic has effective on gram-positive and gram-negative bacteria acts by inhibiting bacterial protein synthesis.

  • SQ609

    SQ609 is a potential anti-tuberculosis drug selected from a library of dipiperidine derivatives.